Not affected in multiple myeloma –
**Core Concept**
Multiple myeloma is a plasma cell malignancy characterized by the clonal proliferation of malignant plasma cells in the bone marrow, leading to an overproduction of a single type of immunoglobulin. The type of immunoglobulin produced is often related to the type of myeloma.
**Why the Correct Answer is Right**
IgM myeloma is rare and typically presents with a different clinical profile compared to other types of myeloma. This is because IgM is a pentameric antibody that can cause hyperviscosity syndrome, leading to neurological symptoms and other complications. In contrast, IgG and IgA myelomas are more common and often present with bone pain, anemia, and renal failure. IgD myeloma is also rare but typically presents with a more aggressive clinical course.
**Why Each Wrong Option is Incorrect**
**Option A:** IgG myeloma is the most common type of myeloma, accounting for approximately 50% of cases, and typically presents with bone pain, anemia, and renal failure.
**Option B:** IgA myeloma is the second most common type of myeloma, accounting for approximately 20% of cases, and often presents with bone pain, anemia, and renal failure.
**Option D:** IgD myeloma is rare and typically presents with a more aggressive clinical course, including anemia, renal failure, and bone pain.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that the type of immunoglobulin produced in multiple myeloma can provide clues about the clinical presentation and prognosis of the disease.
**β Correct Answer: C. IgM. IgM myeloma is rare and typically presents with hyperviscosity syndrome and neurological symptoms.**